Tanja Matijevic Glavan

Dr. Tanja Matijevic Glavan

Rudjer Boskoovic Institute, Zagreb, Croatia
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2014 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
TGTanja Matijevic Glavan
Tanja Matijevic Glavan
JPJasminka Pavelic
Jasminka Pavelic
Toll-like receptors (TLRs) are a group of transmembrane receptors that recognize molecular motifs of pathogen origin and activate immune response. Although TLRs were first identified in immune system cells, recent studies show they can also be expressed in tumor cells. TLR3 recognizes dsRNA or its synthetic ligand poly (I: C) and is responsible primarily for the defense against viral infections. Recent studies showed that TLR3 can trigger apoptosis in cancer cell. Furthermore, other dsRNA binding receptors (MDA5 and RIG-I), localized in cytoplasm, can also bind poly (I: C) and therefore contribute to this effect. With TLR3’s capacity to induce apoptosis and activate the immune system at the same time, TLR3 ligands are an attractive therapeutic option for treatment of cancer. Novel therapies include combining poly (I: C) with other components such as chemotherapeutics, apoptosis enhancers, other TLR ligands and peptides activating the immune system. Slightly modified TLR3 agonists (Ampligen®, Hiltonol®, poly IC-LC) are already being used in clinical studies for cancer therapy as single agents or in combination with other drugs. On the other hand, latest studies forewarn that TLR3 activation can also have tumor promoting role so it is crucial to identify the terms by which TLR3 has pro-tumor/anti-tumor effect in order to safely implement TLR3 ligand based therapy into clinical trials.

22 February 2022 in Molecules
Verified
Journal Article
Open access
PDF file
KTKoraljka Gall Troselj
Koraljka Gall Troselj
MTMarko Tomljanović
Marko Tomljanović
MJMorana Jaganjac
Morana Jaganjac
TGTanja Matijevic Glavan
Tanja Matijevic Glavan
Ana Cipak GasparovicAna Cipak Gasparovic
Ana Cipak Gasparovic
Neven ZarkovicNeven Zarkovic
Neven Zarkovic
Oxidative stress and its end-products, such as 4-hydroxynonenal (HNE), initiate activation of the Nuclear Factor Erythroid 2-Related Factor 2 (NRF2)/Kelch Like ECH Associated Protein 1 (KEAP1) signaling pathway that plays a crucial role in the maintenance of cellular redox homeostasis. However, an involvement of 4-HNE and NRF2 in processes associated with the initiation of cancer, its progression, and response to therapy includes numerous, highly complex events. They occur through interactions between cancer and stromal cells. These events are dependent on many cell-type specific features. They start with the extent of NRF2 binding to its cytoplasmic repressor, KEAP1, and extend to the permissiveness of chromatin for transcription of Antioxidant Response Element (ARE)-containing genes that are NRF2 targets. This review will explore epigenetic molecular mechanisms of NRF2 transcription through the specific molecular anatomy of its promoter. It will explain the role of NRF2 in cancer stem cells, with respect to cancer therapy resistance. Additionally, it also discusses NRF2 involvement at the cross-roads of communication between tumor associated inflammatory and stromal cells, which is also an important factor involved in the response to therapy.

Verified
Journal Article
Open access
PDF file
EZEmilija Zapletal
Emilija Zapletal
TVTea Vasiljevic
Tea Vasiljevic
Pierre BussonPierre Busson
Pierre Busson
TGTanja Matijevic Glavan
Tanja Matijevic Glavan
Damage-associated molecular patterns (DAMPs) are endogenous molecules released from the necrotic cells dying after exposure to various stressors. After binding to their receptors, they can stimulate various signaling pathways in target cells. DAMPs are especially abundant in the microenvironment of malignant tumors and are suspected to influence the behavior of malignant and stromal cells in multiple ways often resulting in promotion of cell proliferation, migration, invasion, and metastasis, as well as increased immune evasion. This review will start with a reminder of the main features of cell necrosis, which will be compared to other forms of cell death. Then we will summarize the various methods used to assess tumor necrosis in clinical practice including medical imaging, histopathological examination, and/or biological assays. We will also consider the importance of necrosis as a prognostic factor. Then the focus will be on the DAMPs and their role in the tumor microenvironment (TME). We will address not only their interactions with the malignant cells, frequently leading to cancer progression, but also with the immune cells and their contribution to immunosuppression. Finally, we will emphasize the role of DAMPs released by necrotic cells in the activation of Toll-like receptors (TLRs) and the possible contributions of TLRs to tumor development. This last point is very important for the future of cancer therapeutics since there are attempts to use TLR artificial ligands for cancer therapeutics.

2 November 2016 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
TGTanja Matijevic Glavan
Tanja Matijevic Glavan
AGAna Cipak Gasparovic
Ana Cipak Gasparovic
BVBenjamin VERILLAUD
Benjamin VERILLAUD
PBPierre Busson
Pierre Busson
JPJasminka Pavelic
Jasminka Pavelic

25 October 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
MVMathieu Veyrat
Mathieu Veyrat
SDSylvère Durand
Sylvère Durand
MCMarion Classe
Marion Classe
TGTanja Matijevic Glavan
Tanja Matijevic Glavan
NONatalie Oker
Natalie Oker
BVBenjamin VERILLAUD
Benjamin VERILLAUD
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells

1 May 2006 in Life Sciences
Verified
Journal Article
Open access
Nela PivacNela Pivac
Nela Pivac
Jelena KnezevicJelena Knezevic
Jelena Knezevic
MMMaja Mustapic
Maja Mustapic
MDMartina Dezeljin
Martina Dezeljin
DMDorotea Muck-Seler
Dorotea Muck-Seler
JPJasminka Pavelic
Jasminka Pavelic
Monoamine oxidase (MAO), a mitochondrial flavine containing enzyme, exists in two isoenzymes, MAO-A and MAO-B. Platelets contain MAO-B subtype, proposed to be a biomarker for different personality characteristics and vulnerability for substance abuse. The most common polymorphism of MAO-B gene, a single base change (A or G) occurs in intron 13. It has been proposed to be a functional polymorphism, controlling the activity of MAO-B in platelets. The aim of the study was to determine the association between platelet MAO-B activity and MAO-B intron 13 polymorphism in 225 racially and ethnically uniform healthy Caucasian men of the Croatian origin. Our results showed that platelet MAO-B activity did not differ between subjects subdivided into those with <> or <>. This polymorphism of the MAO-B gene did not control the activity of the MAO-B in platelets. Platelet MAO-B activity was associated only with the smoking status, and it was significantly decreased in smokers when compared to nonsmokers. No significant association was found between MAO-B polymorphism and smoking status. In healthy individuals of the Croatian origin, the studied MAO-B polymorphism showed a lack of functional importance in regulating MAO-B activity in platelets. Since different populations may vary in the association between functional polymorphism and the MAO-B activity, and the genotype of transcription factor AP-2 beta was reported to be associated with altered platelet MAO-B activity, and with specific personality traits, further studies on different populations should be conducted to elucidate the molecular mechanism/s regulating platelet MAO-B activity.